Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fulgent Genetics, Inc. - Common Stock (NQ:FLGT)

19.85 -0.10 (-0.50%)
Streaming Delayed Price Updated: 3:53 PM EDT, Aug 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Fulgent Genetics, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
Step Aside AMC: Here Are The Most Shorted Stocks Right Now ↗
Just like in late January the common theme here is that all these stocks are extremely heavily shorted, and retail investors are seeking to squeeze the shorts once again and this time with even more... 
Via Talk Markets
News headline image
How Long Will Fulgent Genetics Benefit From the Pandemic? ↗
Genetic testing for the coronavirus is slowing. 
Via The Motley Fool
News headline image
Forget Dogecoin -- Buy These 3 Growth Stocks Instead ↗
They are all coming off some impressive quarterly results. 
Via The Motley Fool
News headline image
A Look Into Healthcare Sector Value Stocks ↗
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
News headline image
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
News headline image
Week In Review: GenScript And Its Legend Bio Subsidiary Raise $1 Billion From Hillhouse ↗
GenScript raised more than $1 billion from Hillhouse Capital in several different investments, including a $500 million commitment to GenScript's Legend Biotech CAR-T subsidiary. Before the... 
Via Talk Markets
News headline image
What Are Investors Thinking About Fulgent Genetics? ↗
Hint: It has something to do with COVID-19. 
Via The Motley Fool
News headline image
Fulgent Genetics Announces Incremental Strategic Investment in Chinese Joint Venture, FF Gene Biotech
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Why Investors Loved Fulgent Genetics' Q1 Results ↗
More than 4,500% revenue growth gave Wall Street and shareholders something to cheer about. 
Via The Motley Fool
News headline image
Fulgent Genetics, Inc. Common Stock (FLGT) Q1 2021 Earnings Call Transcript ↗
FLGT earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Gainers T2 Biosystems (NASDAQ:TTOO) share... 
Via Benzinga
News headline image
Fulgent Genetics Reports Record First Quarter Financial Results
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Fulgent Genetics Welcomes Dr. Lawrence Weiss as Chief Medical Officer
From Fulgent Genetics, Inc.
Via Business Wire
News headline image
Why Shares of Fulgent Genetics Fell 20% in April ↗
Good news for the U.S. has been bad news for shareholders. 
Via The Motley Fool
News headline image
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
2 Numbers That Explain How This Hypergrowth Company Can Make You Rich ↗
The genetic testing giant's journey resembles the path of past winners. 
Via The Motley Fool
News headline image
3 Healthcare Stocks About to be Bolstered by Biden's American Rescue Plan ↗
The government is going to invest heavily in COVID-19 research and tracking, and these companies are likely to benefit. 
Via The Motley Fool
News headline image
2 Unsustainable Growth Stocks to Avoid ↗
Be wary of companies posting abnormal growth rates. 
Via The Motley Fool
News headline image
Fulgent Genetics' CEO Just Told Investors To Look Out For An Acquisition ↗
He also gave clues that point to a few possible targets. 
Via The Motley Fool
News headline image
1 Number That Should Shock Fulgent Genetics Investors ↗
Growth last year was awesome, but there is something to be even more excited about. 
Via The Motley Fool
News headline image
Got $5,000? These 2 Ultra-Cheap Stocks Are Bargain Buys ↗
They've underperformed the S&P 500 in the past month, but these stocks show lots of potential over the long term. 
Via The Motley Fool
Topics Stocks
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.